Results 21 to 30 of about 394,432 (188)

Deciphering the Mechanisms Underlying Brain Alterations and Cognitive Impairment in Congenital Myotonic Dystrophy

open access: yesNeurobiology of Disease, 2021
Myotonic dystrophy type 1 (DM1) is a multisystemic and heterogeneous disorder caused by the expansion of CTG repeats in the 3’ UTR of the myotonic dystrophy protein kinase (DMPK) gene.
Mohamed Chahine   +2 more
exaly   +3 more sources

Muscle Strength and Outcome Measures for Upper Limb Function in Adults With Myotonic Dystrophy Type 1: A Cross‐Sectional Study [PDF]

open access: yesEuropean Journal of Neurology, Volume 33, Issue 11, November 2026.
Adults with Myotonic Dystrophy type 1 showed reduced upper‐limb strength and functional performance. There was considerable variability between participants, indicating the need for multiple outcome measures to capture the range of impairments. ABSTRACT Background Myotonic dystrophy Type 1 (DM1) is a multisystem neuromuscular disorder with progressive ...
Hanne Ludt Fossmo   +5 more
wiley   +2 more sources

Clinically Suspected Myotonic Dystrophy in Sub‐Saharan Africa: A Rare Case Report Highlighting Rehabilitation Challenges [PDF]

open access: yesClinical Case Reports, Volume 14, Issue 8, August 2026.
ABSTRACT Myotonic dystrophy is an autosomal dominant multisystem disorder rarely reported in sub‐Saharan Africa. We report a 30‐year‐old Ethiopian female with progressive weakness, myotonia, positive family history, and characteristic electromyography findings. As there is no curative treatment, management is supportive. This case highlights its rarity
Abraham Sisay Abie   +4 more
wiley   +2 more sources

Neonatal congenital myotonic dystrophy with DMPK gene expansion: clinical features and short-term outcomes [PDF]

open access: yesFrontiers in Pediatrics
ObjectiveTo investigate the clinical manifestations, diagnosis and treatment, and DMPK gene mutations in neonates with congenital myotonic dystrophy (CDM).MethodsA retrospective analysis was conducted on the clinical data of four neonates diagnosed with ...
Qian Zhao   +3 more
doaj   +2 more sources

Transverse colonic volvulus in a 16-year-old female with congenital myotonic dystrophy: A case report

open access: yesJournal of Pediatric Surgery Case Reports, 2015
Transverse colonic accounts for 2–4% of all forms of colonic volvulus and has its highest mortality rate (33) [1–3]. Only forty cases of pediatric transverse colonic volvulus have been reported in the literature to date [4].
Cheryl de Silva   +3 more
doaj   +2 more sources

RNA mis‐splicing in children with congenital myotonic dystrophy is associated with physical function [PDF]

open access: yesAnnals of Clinical and Translational Neurology
Objectives Dysregulated RNA alternative splicing is the hallmark of myotonic dystrophy type 1 (DM1). However, the association between RNA mis‐splicing and physical function in children with the most severe form of disease, congenital myotonic dystrophy ...
Julia M. Hartman   +15 more
doaj   +2 more sources

Complex patterns of male germline instability and somatic mosaicism in myotonic dystrophy type 1 [PDF]

open access: yes, 2000
The genetic basis of myotonic dystrophy type 1 (DM1) is the expansion of a CTG repeat in the 3' untranslated region of DM1PK . Once into the disease range, the repeat becomes highly unstable and is biased toward expansion in both somatic and germline ...
Martorell, L.   +3 more
core   +8 more sources

Respiratory outcomes in children with congenital myotonic dystrophy

open access: yesJournal of Pediatric Rehabilitation Medicine, 2022
PURPOSE: Congenital myotonic dystrophy (CDM) results in hypotonia and acute respiratory distress at birth. Previous studies show that prolonged periods of intubation (>4 weeks) correlate with increased mortality rates.
Jaclyn Omura   +3 more
doaj   +3 more sources

Electronic Devices and Digital Therapeutics in Neuromuscular Diseases: Narrative Review on Current Applications in Patients' Management and Pharmacovigilance [PDF]

open access: yesHealth Care Science, EarlyView.
Digital innovations are revolutionizing neuromuscular disease management by integrating wearable sensors, mobile applications, and telemedicine to enable continuous monitoring and personalized care. These technologies enhance diagnosis, treatment, and drug development fostering dynamic interaction between patients and clinicians paving the way toward ...
Ilaria Saltarella   +8 more
wiley   +2 more sources

Congenital myotonic dystrophy-an RNA-mediated disease across a developmental continuum. [PDF]

open access: yesGenes Dev, 2017
Thomas and colleagues (pp. 1122–1133) demonstrate severe dysregulation of developmentally regulated alternative splicing and polyadenylation in congenital myotonic dystrophy (CDM).
Jagannathan S, Bradley RK.
europepmc   +2 more sources

Home - About - Disclaimer - Privacy